0.328 -0.009 (-2.61%) | 03-27 16:00 | |||||||||||||
|
|
Short term | ||||
Mid term | ||||
Targets | 6-month : | 0.58 | 1-year : | 0.71 |
Resists | First : | 0.5 | Second : | 0.61 |
Pivot price | 0.37 | |||
Supports | First : | 0.32 | Second : | 0.27 |
MAs | MA(5) : | 0.34 | MA(20) : | 0.41 |
MA(100) : | 0.54 | MA(250) : | 0.77 | |
MACD | MACD : | -0.1 | Signal : | -0.1 |
%K %D | K(14,3) : | 5 | D(3) : | 7.3 |
RSI | RSI(14): 32.2 | |||
52-week | High : | 1.42 | Low : | 0.32 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ AIH ] has closed above bottom band by 27.6%. Bollinger Bands are 4.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
If tomorrow: | Open lower | Open higher |
High: | 0.34 - 0.34 | 0.34 - 0.34 |
Low: | 0.32 - 0.32 | 0.32 - 0.32 |
Close: | 0.32 - 0.33 | 0.33 - 0.33 |
Aesthetic Medical International Holdings Group Limited provides aesthetic medical services. It offers surgical aesthetic treatments, such as eye surgery, rhinoplasty, breast augmentation, and liposuction; and non-surgical aesthetic treatments comprising minimally invasive and energy-based treatments, including laser, ultrasound, and ultraviolet light treatments. The company also provides general healthcare and other aesthetic medical services, such as internal medicine, urology, gynecology, and obstetrics treatment services, as well as dentistry, dermatology, and hair loss treatment services. It operates 15 treatment centers in China, Hong Kong, and Singapore. Aesthetic Medical International Holdings Group Limited was founded in 1997 and is headquartered in Shenzhen, the People's Republic of China.
Wed, 13 Mar 2024
Aesthetic Medical International Holdings Group Limited (NASDAQ:AIH) Sees Significant Growth in Short Interest - Defense World
Sun, 10 Mar 2024
Alternatives to Silicone Breast Implants and 10 Cheap Countries for Augmentation - Yahoo Finance
Fri, 08 Mar 2024
Aesthetic Medical International Holdings Group Ltd. Announces Receipt of a Letter of Expected Delisting Determination ... - GlobeNewswire
Tue, 12 Dec 2023
Aesthetic Medical International Announces Change of Auditor and Change of Director - Yahoo Finance
Fri, 08 Sep 2023
Aesthetic Medical International Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price ... - Yahoo Finance
Wed, 17 May 2023
Aesthetic Medical International Reports First Quarter 2023 Unaudited Financial Results - GlobeNewswire
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
Exchange:
NASDAQ
|
|
Sector:
Healthcare
|
|
Industry:
Medical - Care Facilities
|
|
Shares Out | 48 (M) |
Shares Float | 1 (M) |
Held by Insiders | 0 (%) |
Held by Institutions | 1.4 (%) |
Shares Short | 45 (K) |
Shares Short P.Month | 38 (K) |
EPS | -0.39 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 1.03 |
Profit Margin | -12.6 % |
Operating Margin | -8 % |
Return on Assets (ttm) | -4.4 % |
Return on Equity (ttm) | 0 % |
Qtrly Rev. Growth | -4.2 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 13.68 |
EBITDA (p.s.) | -0.57 |
Qtrly Earnings Growth | 0 % |
Operating Cash Flow | 0 (M) |
Levered Free Cash Flow | 0 (M) |
PE Ratio | -0.85 |
PEG Ratio | 0 |
Price to Book value | 0.31 |
Price to Sales | 0.02 |
Price to Cash Flow | 0 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |